ITPA gene variants markedly affect risk of recurrence of hepatitis C after treatment. PDF Print
Sahlgrenska Academy: Martin Lagging and co-workers at the Sahlgrenska Academy have studied an enzyme called inosine trifosfatas (ITPase), which normally prevents the incorporation of defective building blocks into RNA and DNA. Unexpectedly they found that the gene encoding for ITPase (ITPA) had significance for the treatment outcome in chronic hepatitis C virus infection.

...

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.